Gland Pharma gets 2 USFDA observations for Pashamylaram Facility Ruchika Sharma28 Aug 2023 2:30 PM ISTTelangana: Gland Pharma has announced that the Office of Medical Device and Radiological Health Operations (OMDRHO), United States Food and...
Sun Pharma looking to fully acquire Israel based unit Taro Pharmaceutical Industries: MD Dilip Shanghvi Ruchika Sharma28 Aug 2023 1:30 PM ISTSun Pharma currently owns around 78 per cent stake in Taro.
Merck, Eisai to shut down late stage study for combo cancer therapy Ruchika Sharma28 Aug 2023 12:31 PM ISTThe companies are testing the combination to treat a range of cancers, including those affecting the lungs and stomach.
Alnylam plans to appeal ruling on patents related to Moderna COVID vaccine Ruchika Sharma28 Aug 2023 11:30 AM ISTBengaluru: Alnylam Pharmaceuticals has said it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents...
USFDA nod to Gilead Sciences Veklury to treat COVID19 in people with mild to severe hepatic impairment with no dose adjustment Ruchika Sharma27 Aug 2023 2:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug...
Indian Immunologicals expects to commercially launch dengue fever vaccine by early 2026 Ruchika Sharma27 Aug 2023 12:30 PM ISTIIL's managing director, K Anand Kumar, said the vaccine's early stage trials conducted on about 90 individuals, aged 18-50 years, did not demonstrate...
Pfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older adults Ruchika Sharma27 Aug 2023 11:00 AM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, the company’s bivalent...
Cigna removes pre authorization requirement for 25 percent of medical services Ruchika Sharma27 Aug 2023 9:00 AM ISTUnited States: Health insurer Cigna Group said on Thursday it would remove the use of prior authorization or paperwork required to get approval for...
Zydus Lifesciences to present on ZYIL1 at International Congress of Parkinson's Disease and Movement Disorders Ruchika Sharma26 Aug 2023 1:30 PM ISTZYIL1 is a novel oral small molecule NLRP3 inhibitor.
Pfizer gets USFDA priority review for prostate cancer drug Xtandi Ruchika Sharma26 Aug 2023 12:00 PM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer Ruchika Sharma26 Aug 2023 11:30 AM ISTCambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of...
Sandoz bags USFDA approval for biosimilar Tyruko for relapsing forms of multiple sclerosis Ruchika Sharma26 Aug 2023 11:00 AM ISTTyruko has the same intravenous dosage form, route of administration, dosing regimen and presentation as the reference medicine.
